Blair William & CO Astrazeneca PLC Transaction History

Blair William & CO

$33.4 Billion
Q3 2024

A detailed history of Blair William & CO transactions in Astrazeneca PLC stock. As of the latest transaction made, Blair William & CO holds 235,447 shares of AZN stock, worth $15.6 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

235,447

Previous 229,484 2.6%

Holding current value

$15.6 Million

Previous $17.9 Million 2.51%

% of portfolio

0.05%

Previous 0.06%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$76.67 - $87.62 $457,183 - $522,478	5,963 Added 2.6%	235,447 $18.3 Million
Q2 2024 Aug 12, 2024	SELL	$66.81 - $80.83 $395,515 - $478,513	-5,920 Reduced 2.51%	229,484 $17.9 Million
Q1 2024 May 09, 2024	SELL	$61.03 - $69.57 $734,496 - $837,274	-12,035 Reduced 4.86%	235,404 $15.9 Million
Q4 2023 Feb 12, 2024	SELL	$61.89 - $69.28 $1.19 Million - $1.33 Million	-19,194 Reduced 7.2%	247,439 $16.7 Million
Q3 2023 Nov 09, 2023	SELL	$64.85 - $71.7 $3.27 Million - $3.62 Million	-50,425 Reduced 15.9%	266,633 $18.1 Million
Q2 2023 Aug 11, 2023	SELL	$69.91 - $75.81 $324,312 - $351,682	-4,639 Reduced 1.44%	317,058 $22.7 Million
Q1 2023 May 12, 2023	SELL	$63.15 - $71.6 $383,573 - $434,898	-6,074 Reduced 1.85%	321,697 $22.3 Million
Q4 2022 Feb 10, 2023	SELL	$54.21 - $70.44 $324,338 - $421,442	-5,983 Reduced 1.79%	327,771 $22.2 Million
Q3 2022 Nov 09, 2022	SELL	$53.02 - $135.75 $1.17 Million - $2.99 Million	-22,037 Reduced 6.19%	333,754 $18.3 Million
Q2 2022 Aug 10, 2022	BUY	$59.26 - $71.14 $933,522 - $1.12 Million	15,753 Added 4.63%	355,791 $23.5 Million
Q1 2022 May 13, 2022	SELL	$55.72 - $67.12 $563,273 - $678,516	-10,109 Reduced 2.89%	340,038 $22.6 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $1.36 Million - $1.61 Million	-25,157 Reduced 6.7%	350,147 $20.4 Million
Q3 2021 Nov 12, 2021	SELL	$55.56 - $60.79 $352,305 - $385,469	-6,341 Reduced 1.66%	375,304 $22.5 Million
Q2 2021 Aug 12, 2021	BUY	$48.42 - $60.18 $1.18 Million - $1.47 Million	24,456 Added 6.85%	381,645 $22.9 Million
Q1 2021 May 13, 2021	SELL	$47.16 - $54.44 $4.67 Million - $5.4 Million	-99,114 Reduced 21.72%	357,189 $17.8 Million
Q4 2020 Feb 09, 2021	SELL	$48.52 - $58.02 $250,217 - $299,209	-5,157 Reduced 1.12%	456,303 $22.8 Million
Q3 2020 Nov 06, 2020	BUY	$53.07 - $61.1 $1.29 Million - $1.48 Million	24,280 Added 5.55%	461,460 $25.3 Million
Q2 2020 Aug 12, 2020	SELL	$43.1 - $55.31 $92,449 - $118,639	-2,145 Reduced 0.49%	437,180 $23.1 Million
Q1 2020 May 11, 2020	SELL	$37.79 - $51.33 $1.37 Million - $1.86 Million	-36,282 Reduced 7.63%	439,325 $19.6 Million
Q4 2019 Feb 13, 2020	BUY	$42.46 - $50.46 $950,042 - $1.13 Million	22,375 Added 4.94%	475,607 $23.7 Million
Q3 2019 Nov 12, 2019	BUY	$40.12 - $45.47 $900,774 - $1.02 Million	22,452 Added 5.21%	453,232 $20.2 Million
Q2 2019 Aug 13, 2019	BUY	$37.28 - $41.68 $1.01 Million - $1.13 Million	27,030 Added 6.69%	430,780 $17.8 Million
Q1 2019 May 14, 2019	BUY	$35.49 - $43.02 $311,353 - $377,414	8,773 Added 2.22%	403,750 $16.3 Million
Q4 2018 Feb 14, 2019	SELL	$36.86 - $41.49 $759,094 - $854,445	-20,594 Reduced 4.96%	394,977 $15 Million
Q3 2018 Nov 13, 2018	BUY	$34.76 - $39.72 $1.43 Million - $1.63 Million	41,151 Added 10.99%	415,571 $16.4 Million
Q2 2018 Aug 13, 2018	BUY	$34.55 - $37.05 $2.74 Million - $2.94 Million	79,387 Added 26.91%	374,420 $13.1 Million
Q1 2018 May 15, 2018	BUY	$32.97 - $36.63 $1.84 Million - $2.05 Million	55,841 Added 23.35%	295,033 $10.3 Million
Q4 2017 Feb 14, 2018	BUY	$32.09 - $34.78 $1.8 Million - $1.95 Million	56,183 Added 30.7%	239,192 $8.3 Million
Q3 2017 Nov 13, 2017	BUY	$28.96 - $34.0 $5.3 Million - $6.22 Million	183,009	183,009 $6.2 Million

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $205B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account